93 related articles for article (PubMed ID: 31769665)
21. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
[TBL] [Abstract][Full Text] [Related]
22. Large-scale analysis of influenza A virus nucleoprotein sequence conservation reveals potential drug-target sites.
Kukol A; Hughes DJ
Virology; 2014 Apr; 454-455():40-7. PubMed ID: 24725930
[TBL] [Abstract][Full Text] [Related]
23. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
[TBL] [Abstract][Full Text] [Related]
24. Host Protein Moloney Leukemia Virus 10 (MOV10) Acts as a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein.
Zhang J; Huang F; Tan L; Bai C; Chen B; Liu J; Liang J; Liu C; Zhang S; Lu G; Chen Y; Zhang H
J Virol; 2016 Apr; 90(8):3966-3980. PubMed ID: 26842467
[TBL] [Abstract][Full Text] [Related]
25. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.
Tilmanis D; van Baalen C; Oh DY; Rossignol JF; Hurt AC
Antiviral Res; 2017 Nov; 147():142-148. PubMed ID: 28986103
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
Belardo G; Cenciarelli O; La Frazia S; Rossignol JF; Santoro MG
Antimicrob Agents Chemother; 2015 Feb; 59(2):1061-9. PubMed ID: 25451059
[TBL] [Abstract][Full Text] [Related]
28. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
[TBL] [Abstract][Full Text] [Related]
29. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity.
Yamada H; Nagase S; Takahashi K; Sakoda Y; Kida H; Okamoto S
Antiviral Res; 2016 May; 129():81-92. PubMed ID: 26923882
[TBL] [Abstract][Full Text] [Related]
31. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.
Watanabe K; Ishikawa T; Otaki H; Mizuta S; Hamada T; Nakagaki T; Ishibashi D; Urata S; Yasuda J; Tanaka Y; Nishida N
Sci Rep; 2017 Aug; 7(1):9500. PubMed ID: 28842649
[TBL] [Abstract][Full Text] [Related]
32. Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.
Mathew S; Al Thani AA; Yassine HM
PLoS One; 2018; 13(9):e0203148. PubMed ID: 30180218
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and cellular uptake of p-[(123)I]-phenyl-amino-thiazole ((123)I-PAT) as a potential agent for targeting tubulin polymerization in tumors.
Wang DM; Kuo JW; Kuo WT; Hsu CF; Wang MH; Chang Y; Lin WJ; Wang JT
J Labelled Comp Radiopharm; 2014 Mar; 57(3):132-5. PubMed ID: 24408319
[TBL] [Abstract][Full Text] [Related]
34. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
35. Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin.
Lin D; Luo Y; Yang G; Li F; Xie X; Chen D; He L; Wang J; Ye C; Lu S; Lv L; Liu S; He J
Biochem Pharmacol; 2017 Nov; 144():35-51. PubMed ID: 28774731
[TBL] [Abstract][Full Text] [Related]
36. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
[TBL] [Abstract][Full Text] [Related]
37. Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity.
Khalil H; Abd El Maksoud AI; Roshdey T; El-Masry S
J Med Virol; 2019 Jan; 91(1):45-55. PubMed ID: 30153335
[TBL] [Abstract][Full Text] [Related]
38. 4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling.
Trist IM; Nannetti G; Tintori C; Fallacara AL; Deodato D; Mercorelli B; Palù G; Wijtmans M; Gospodova T; Edink E; Verheij M; de Esch I; Viteva L; Loregian A; Botta M
J Med Chem; 2016 Mar; 59(6):2688-703. PubMed ID: 26924568
[TBL] [Abstract][Full Text] [Related]
39. Regulation of influenza A virus nucleoprotein oligomerization by phosphorylation.
Turrell L; Hutchinson EC; Vreede FT; Fodor E
J Virol; 2015 Jan; 89(2):1452-5. PubMed ID: 25355893
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays.
Hagiwara K; Kondoh Y; Ueda A; Yamada K; Goto H; Watanabe T; Nakata T; Osada H; Aida Y
Biochem Biophys Res Commun; 2010 Apr; 394(3):721-7. PubMed ID: 20230782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
